Alpha Tau Medical and Three Promising Penny Stocks to Watch

Here’s a paraphrased version of your article, structured in HTML format with headings and approximately seven paragraphs:

<div class="atoms-wrapper">
    <p class="yf-1090901"><strong>Market Reactions to Trade Deal</strong> As the U.S. stock market rises following reports of a trade agreement with the UK, investors are closely monitoring the potential impacts on various sectors, particularly smaller-cap stocks. Penny stocks, typically linked to smaller or newer firms, still present attractive growth opportunities at lower price points, despite the term being somewhat considered outdated. By concentrating on robust financials and solid fundamentals, these lesser-known investments could offer appealing prospects for those venturing beyond mainstream market options.</p>

    <div class="table-container yf-t4vsm6">
        <table class="article-table yf-t4vsm6">
            <tbody>
                <tr>
                    <td data-testid="cell-0-0"><strong>Name</strong></td>
                    <td data-testid="cell-0-1"><strong>Share Price</strong></td>
                    <td data-testid="cell-0-2"><strong>Market Cap</strong></td>
                    <td data-testid="cell-0-3"><strong>Financial Health Rating</strong></td>
                </tr>
                <tr>
                    <td data-testid="cell-1-0">Safe Bulkers (NYSE:SB)</td>
                    <td data-testid="cell-1-1">$3.39</td>
                    <td data-testid="cell-1-2">$358.57M</td>
                    <td data-testid="cell-1-3">★★★★☆☆</td>
                </tr>
                <tr>
                    <td data-testid="cell-2-0">Tuya (NYSE:TUYA)</td>
                    <td data-testid="cell-2-1">$2.29</td>
                    <td data-testid="cell-2-2">$1.39B</td>
                    <td data-testid="cell-2-3">★★★★★★</td>
                </tr>
                <tr>
                    <td data-testid="cell-3-0">Smith Micro Software (NasdaqCM:SMSI)</td>
                    <td data-testid="cell-3-1">$1.045</td>
                    <td data-testid="cell-3-2">$16.42M</td>
                    <td data-testid="cell-3-3">★★★★☆☆</td>
                </tr>
                <tr>
                    <td data-testid="cell-4-0">Kiora Pharmaceuticals (NasdaqCM:KPRX)</td>
                    <td data-testid="cell-4-1">$3.35</td>
                    <td data-testid="cell-4-2">$9.9M</td>
                    <td data-testid="cell-4-3">★★★★★★</td>
                </tr>
                <tr>
                    <td data-testid="cell-5-0">Flexible Solutions International (NYSEAM:FSI)</td>
                    <td data-testid="cell-5-1">$3.60</td>
                    <td data-testid="cell-5-2">$45.28M</td>
                    <td data-testid="cell-5-3">★★★★★★</td>
                </tr>
                <tr>
                    <td data-testid="cell-6-0">Imperial Petroleum (NasdaqCM:IMPP)</td>
                    <td data-testid="cell-6-1">$2.63</td>
                    <td data-testid="cell-6-2">$89.65M</td>
                    <td data-testid="cell-6-3">★★★★★★</td>
                </tr>
                <tr>
                    <td data-testid="cell-7-0">Heritage Global (NasdaqCM:HGBL)</td>
                    <td data-testid="cell-7-1">$1.975</td>
                    <td data-testid="cell-7-2">$70.64M</td>
                    <td data-testid="cell-7-3">★★★★★★</td>
                </tr>
                <tr>
                    <td data-testid="cell-8-0">BAB (OTCPK:BABB)</td>
                    <td data-testid="cell-8-1">$0.84</td>
                    <td data-testid="cell-8-2">$6.12M</td>
                    <td data-testid="cell-8-3">★★★★★★</td>
                </tr>
                <tr>
                    <td data-testid="cell-9-0">Lifetime Brands (NasdaqGS:LCUT)</td>
                    <td data-testid="cell-9-1">$3.29</td>
                    <td data-testid="cell-9-2">$72.4M</td>
                    <td data-testid="cell-9-3">★★★★★☆</td>
                </tr>
                <tr>
                    <td data-testid="cell-10-0">CBAK Energy Technology (NasdaqCM:CBAT)</td>
                    <td data-testid="cell-10-1">$0.843</td>
                    <td data-testid="cell-10-2">$74.37M</td>
                    <td data-testid="cell-10-3">★★★★★☆</td>
                </tr>
            </tbody>
        </table>
    </div>

    <p class="yf-1090901">The article will explore a selection of stocks from our recent screener results.</p>

    <p class="yf-1090901"><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>

    <p class="yf-1090901"><strong>Company Overview:</strong> Alpha Tau Medical Ltd. is a clinical-stage company focused on developing its diffusing alpha-emitters radiation therapy (Alpha DaRT) for solid cancer treatment. Presently, its market cap is approximately $182.29 million.</p>

    <p class="yf-1090901"><strong>Company Operations:</strong> The firm does not currently report any revenue segments as it is concentrating on its therapeutic developments. However, it has raised substantial funds and has sufficient assets to maintain operations for over two years.</p>

    <p class="yf-1090901"><strong>Financial Health Insight:</strong> Although unprofitable, Alpha Tau Medical Ltd. has a solid cash base and experienced leadership. They recently secured FDA approval for a clinical study, aiming to enhance their growth trajectory, despite potential share dilution risks.</p>

    <p class="yf-1090901"><em>This article offers general insights and is not intended as financial advice. The analysis is based on historical data and analyst projections, focusing on long-term evaluations driven by fundamental data.</em></p>

    <p class="yf-1090901"><em>Companies mentioned include Alpha Tau Medical, Mynd.ai, and Granite Point Mortgage Trust.</em></p>
</div>

This structure maintains the core information while ensuring clarity and readability.